Executive Function

An aspirin a day does not keep dementia at bay
March 25, 2020
Taking a low-dose aspirin once a day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable Alzheimer's disease, nor does it slow the rate of cognitive decline, according to a large study published in the March 25, 2020, online issue of ®, the...
Read More
Mother/infant skin-to-skin touch boosts baby's brain development and function
March 25, 2020
As the world prioritizes social distancing to stop or slow down the spread of coronavirus (COVID-19), a new study by researchers at Florida Atlantic University demonstrates that mother-infant touch and contact are essential for optimal neurodevelopmental regulation in early infancy. Kangaroo Care...
Read More
Stroke: When the system fails for the second time
March 23, 2020
After a stroke, there is an increased risk of suffering a second one. If areas in the left hemisphere were affected during the first attack, language is often impaired. In order to maintain this capability, the brain usually briefly drives up the counterparts on the right side. But what happens a...
Read More
Ritalin and similar medications cause brain to focus on benefits of work, not costs
March 19, 2020
Common assumption has long held that Ritalin, Adderall and similar drugs work by helping people focus.
Yet a new study from a team led in part by Brown University researchers shows that these medications -- usually prescribed to individuals diagnosed with attention deficit hyperactivi...
Read More
Researchers find key to keep working memory working
March 19, 2020
Working memory, the ability to hold a thought in mind even through distraction, is the foundation of abstract reasoning and a defining characteristic of the human brain. It is also impaired in disorders such as schizophrenia and Alzheimer's disease.
Now Yale researchers have found a k...
Read More
Seductive details inhibit learning
March 19, 2020
When teachers use a funny joke, a cat video or even background music in their lessons, it can keep students from understanding the main content.
These so-called "seductive details," information that is interesting but irrelevant, can be detrimental to learning, according to a meta-ana...
Read More
Could disease pathogens be the dark matter behind Alzheimer's disease?
March 18, 2020
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Scientists have made exponential advances in understanding many aspects of the mysterious disease since it was fi...
Read More
A new window into psychosis
March 18, 2020
A recent study in mice led a team of researchers in Japan to believe that psychosis may be caused by problems with specialized nerve cells deep within the brain, as well as a certain kind of learning behavior. The researchers hope this could provide insight into the emergence of delusions in pati...
Read More
Alzheimer risk genes converge on microglia
March 18, 2020
Our DNA determines a large part of our risk for Alzheimer's disease, but it remained unclear how many genetic risk factors contribute to disease. A team led by Prof. Bart De Strooper (VIB-KU Leuven) and Dr. Mark Fiers now show that many of risk factors affect brain maintenance cells called microg...
Read More
Brain-doping produced by your own body
March 13, 2020
Erythropoietin, or Epo for short, is a notorious doping agent. It promotes the formation of red blood cells, leading thereby to enhanced physical performance -- at least, that is what we have believed until now. However, as a growth factor, it also protects and regenerates nerve cells in the brai...
Read More
Page 4 of 17
1 2 3 4 5 6 17